益佰制药(600594.SH)：预计2025年度归属于上市公司股东的净利润为负值

Core Viewpoint - Yibai Pharmaceutical (600594.SH) announced that it expects a negative net profit attributable to shareholders for the fiscal year 2025, indicating an anticipated operational loss for the company in that year [1] Financial Performance - The company’s financial department has conducted preliminary calculations, leading to the expectation of a loss in 2025 [1]